Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu
Ein Forscher träufelt aus einer kleinen Pipette eine Flüssigkeit in ein Reagenzglas. Mehrere Reagenzgläser und ein Erlenmeyerkolben vorn rechts sind mit einer hellblauen, klaren Flüssigkeit gefüllt. Kopf und Schultern des Forschers sind nur unscharf im Hintergrund zu erkennen.

Research Group: Neuroendocrine Tumors (NETs)

You are here:

Research Projects:

Clinical Science

  • Clinical trials on new oral- and parenteral-active drugs
  • New treatment approaches in radioreceptor therapy
  • Local sclerotherapy in comparison with alternative treatments
  • Treatment of the carcinoid heart disease (Hedinger syndrome) with non-surgical/non-invasive procedures

Basic Science

  • Studies to improve the early detection of tumors by molecular imaging using optical and radioactive methods. Eligible candidate ligands for imaging are determined with the aid of a large number of defined fluorescence- or radioactive-labeled receptor ligands.
  • Studies to improve the understanding and treatment of carcinoid syndrome, Zollinger-Ellison syndrome and “hypoglycemic” syndrome: By the means of vesicular secretion analyzes and functional analyzes of channel- and receptor-proteins (e.g. GABA receptors, vesicular monoamine transporters, calcium and TRP channels, etc.)

Tumor Growth:

Creation of molecular fingerprints of individual tumors and use of the resulting knowledge of changed molecular parameters for the therapy and clinical practice.